Kimberly Schluns
About Kimberly Schluns
Kimberly Schluns serves as a Senior Director at Kite Pharma, where she focuses on soluble IL-15 complexes and has expertise in tumor microenvironment and mucosal immunity. With over 20 years of research experience in T cell immunology, she has held various academic positions and earned her PhD in Cell Biology/Immunology from Loyola University Chicago.
Work at Kite Pharma
Kimberly Schluns has been serving as Senior Director at Kite Pharma since 2020. Located in Santa Monica, California, she has contributed to the company's focus on innovative cancer therapies. Her role encompasses overseeing research initiatives related to immunology and the tumor microenvironment, particularly in the context of soluble IL-15 complexes.
Education and Expertise
Kimberly Schluns holds a Bachelor of Science in Physiology from the University of Illinois at Urbana-Champaign, where she studied from 1985 to 1989. She furthered her education at Loyola University Chicago, earning a Doctor of Philosophy in Cell Biology/Immunology from 1991 to 1997. Additionally, she completed postdoctoral training in Immunology at The University of Connecticut Health Center.
Background
With over 20 years of research experience in T cell immunology, Kimberly Schluns has developed a strong foundation in the field. Prior to her current position, she worked at MD Anderson Cancer Center for a decade, first as an Assistant Professor from 2004 to 2010 and then as an Associate Professor from 2010 to 2020. She also served as a Postdoctoral Fellow at the University of Connecticut from 1997 to 2004.
Research Experience
Kimberly Schluns has extensive experience in various research methodologies, including Flow Cytometry, Animal Models, Adoptive T cell transfers, Molecular Biology, and Cell Culture. She has led a research team focused on the differentiation of CD8 T cells and lymphocyte development, contributing significantly to the understanding of immune responses.
Achievements in Immunology
Throughout her career, Kimberly Schluns has made notable contributions to the study of tumor microenvironment and mucosal immunity. Her work on soluble IL-15 complexes has provided insights into immune regulation and activity, enhancing the understanding of T cell behavior in cancer therapy.